Use of Human Papillomavirus DNA, E6/E7 mRNA, and p16 Immunocytochemistry to Detect and Predict anal High-Grade Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Men Who Have Sex with Men
Open Access
- 12 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e78291
Abstract
Men who have sex with men (MSM) are at high risk of having anal cancer. Anal high-grade squamous intraepithelial lesion (HSIL) is the precursor of anal cancer. We explored the use of different biomarkers associated with human papillomavirus (HPV) infection and HPV-mediated cell transformation to detect and predict HSIL among HIV-positive and HIV-negative MSM. A total of 123 HIV-positive and 123 HIV-negative MSM were enrolled and followed for 12 months. High-resolution anoscopy (HRA) with biopsies were performed at every visit along with anal sample collection for cytology, high-risk HPV DNA genotyping, HPV E6/E7 mRNA, and p16 immunocytochemistry. Performance characteristics and area under the receiver operator characteristics curve were calculated for these biomarkers at baseline, and Cox regression compared the usefulness of these biomarkers in predicting incident HSIL. High-risk HPV DNA, E6/E7 mRNA, and p16 immunocytochemistry each identified 43–46% of MSM whose baseline test positivity would trigger HRA referral. E6/E7 mRNA had the highest sensitivity (64.7%) and correctly classified the highest number of prevalent HSIL cases. With the exception of p16 immunochemistry, most tests showed significant increases in sensitivity but decreases specificity versus anal cytology, while the overall number of correctly classified cases was not significantly different. Baseline or persistent type 16 and/or 18 HPV DNA was the only test significantly predicting incident histologic HSIL within 12 months in models adjusted for HIV status and low-grade squamous intraepithelial lesions at baseline. Countries with a high HIV prevalence among MSM and limited HRA resources may consider using biomarkers to identify individuals at high risk of HSIL. E6/E7 mRNA had the highest sensitivity for prevalent HSIL detection regardless of HIV status, whereas type 16 and/or 18 HPV DNA performed best in predicting development of incident HSIL within 12 months.Keywords
This publication has 28 references indexed in Scilit:
- Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with menJournal of Clinical Virology, 2012
- Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: Predictors and clinical implicationsGynecologic Oncology, 2011
- HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIVClinical Infectious Diseases, 2011
- P16/CDKN2A and Ki-67 Enhance the Detection of Anal Intraepithelial Neoplasia and Condyloma and Correlate With Human Papillomavirus Detection by Polymerase Chain ReactionAmerican Journal of Surgical Pathology, 2010
- Performance Characteristics of Anal Cytology and Human Papillomavirus Testing in Patients with High-Resolution Anoscopy-Guided Biopsy of High-Grade Anal Intraepithelial NeoplasiaDiseases of the Colon & Rectum, 2009
- Matched-Sample Analysis: Sensitivity, Specificity, and P ValuesClinical Infectious Diseases, 2008
- Anal Human Papillomavirus Testing with Digene's Hybrid Capture 2 Using Two Different Sampling MethodsDiseases of the Colon & Rectum, 2008
- MALIGNANT PROGRESSION OF ANAL INTRA‐EPITHELIAL NEOPLASIAAnz Journal of Surgery, 2006
- HIV/AIDS: Screening HIV‐Infected Individuals for Anal Cancer Precursor Lesions: A Systematic ReviewClinical Infectious Diseases, 2006
- Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infectionJournal of the American Academy of Dermatology, 2005